Results 31 to 40 of about 25,779 (213)

Enhanced Immunogenicity of an Influenza Ectodomain Matrix-2 Protein Virus-like Particle (M2e VLP) Using Polymeric Microparticles for Vaccine Delivery

Viruses, 2022
In this study, we demonstrate how encapsulating a conserved influenza ectodomain matrix-2 protein virus-like particle (M2e5x VLP) into a pre-crosslinked bovine serum albumin (BSA) polymeric matrix enhances in vitro antigen immunogenicity and in vivo ...
Keegan Braz Gomes, Ipshita Menon, Priyal Bagwe, Lotika Bajaj, Sang-Moo Kang, Martin J. D’Souza   +5 more
doaj   +1 more source

0. Prologue | The 2023 UCF VLP Institute Podcast Series

, 2023
Welcome to The 2023 UCF Veterans Legacy Program (VLP) Institute Podcast Series, a limited narrative podcast series directed, produced, written, edited, and hosted by Sebastian Garcia.
Garcia, Sebastian
core  

7. “That Felt So Personal” | The 2023 UCF VLP Institute Podcast Series

, 2023
In the seventh episode of “The 2023 UCF VLP Institute Podcast Series,” we pick back up where we left off last week: the conclusion of the “meta” field trip and into the roundtable discussion about it.
Garcia, Sebastian
core  

ZIKV VLP protein convex hull scoring.

, 2023
The a) lowest scoring (most inner) and b) median scoring (middle) and c) highest scoring (most outer) VLP protein residue center of masses obtained from convex hull analysis are shown.
Daniel W. Biner (4998128), Peter J. Ortoleva (1613785), Jason S. Grosch (14797768)   +2 more
core   +1 more source

A study of the safety and immunogenicity of a new vaccine for the prevention of COVID-19 based on virus-like particles in phase I clinical trials

Журнал микробиологии, эпидемиологии и иммунобиологии
Introduction. One of the more promising developments in preventing the spread of infections, including COVID-19, is the production of vaccines based on virus-like particles (VLP).
Tatiana V. Grebennikova, Olga N. Zaykova, Alexey A. Plotnikov, Lyudmila V. Kostina, Yana Yu. Chernoryzh, Olesia V. Eliseeva, Oleg E. Latyshev, Viktor F. Larichev, Irina T. Fedyakina, Milana A. Losich, Ilya M. Kirillov, Ilya E. Filatov, Marina V. Balandina, Valery V. Tsibezov, Kirill I. Yurlov, Ekaterina I. Lesnova, Valeria M. Kondratieva, Alina A. Kozlova, Marina S. Baranets, Aleksandr L. Gintsburg   +19 more
doaj   +1 more source

Generation and immunogenicity assessment of ELPylated virus-like particles of porcine circovirus type 2

Virology Journal, 2020
Background Porcine circovirus type 2 (PCV2) is an economically important pathogen affecting swine industry worldwide. The production of current PCV2 vaccines is time-consuming and expensive.
Yangyang Li, Yajie Wang, Jian Cheng, Xiaohui Zhou, Huipeng Lu, Xinyu Zhang, Xiaoli Xia, Huaichang Sun   +7 more
doaj   +1 more source

SCOPE KM1605 VLP abundance

, 2020
SCOPE KM1605 VLP ...
Lindell lab
core   +1 more source

Immunogenicity and protective efficacy of human metapneumovirus virus-like particles produced by a recombinant baculovirus in mice

Virus Research, 2023
Background: Human metapneumovirus (HMPV) causes respiratory tract infections among infant, elderly, and immunocompromised patients, with significant mortality. Currently no licensed vaccines or therapeutic agents of HMPV exist.
Fenlian Ma, Aijun Chen, Lihong Yao, Hanchun Gao, Qian Zhang, Wenzhe Hou, Lishu Zheng   +6 more
doaj   +1 more source

Engineering Microbial Particles for Next‐Generation Biomedical Platforms

Advanced Science, EarlyView.
Microbe‐derived particles (MDPs), which include extracellular vesicles, outer membrane vesicles, inclusion bodies, polysaccharide particles, and virus‐like particles, represent a rapidly expanding category of bioinspired nanomaterials. With their natural origin, intrinsic biocompatibility, and highly programmable functionality, MDPs serve as a ...
Yuting Li, Yunjie Lu, Ziyan Huang, Jianjiang Chen, Yanbin Liu, Lei Qin, Chao Wang, Yumin Wu   +7 more
wiley   +1 more source

SCOPE KM1502 VLP abundance

, 2020
SCOPE KM1502 VLP ...
Lindel
core   +1 more source